Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

manilatimes.net · 2026-09-01

FLORHAM PARK, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team are scheduled to participate in the following upcoming investor conferences in September:

TickrTrends take: Phathom Pharmaceuticals' participation in upcoming investor conferences provides an opportunity for the market to gain visibility into the company's strategic direction and pipeline progress, which are key factors in establishing a comprehensive valuation for the Healthcare sector company. With TickrTrends currently awaiting full valuation input on PHAT, investor conference presentations could supply additional operational and financial context that helps inform the company's market assessment. For valuation-focused observers, these conferences will be significant touchpoints for understanding PHAT's competitive positioning and near-term catalysts within the pharmaceutical industry.

Read the full story at manilatimes.net →